Bio-techne Corp. Earnings

Bio-techne Corp.’s revenue jumped 3.55% since last year same period to $316.96Mn in the Q2 2025. On a quarterly growth basis, Bio-techne Corp. has generated 0.25% jump in its revenue since last 3-months.

Bio-techne Corp.’s net profit fell -143.55% since last year same period to $-17.68Mn in the Q2 2025. On a quarterly growth basis, Bio-techne Corp. has generated -178.26% fall in its net profits since last 3-months.

Bio-techne Corp.’s net profit margin fell -142.06% since last year same period to -5.58% in the Q2 2025. On a quarterly growth basis, Bio-techne Corp. has generated -178.07% fall in its net profit margins since last 3-months.

Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.43 - a -14% fall from last quarter’s estimates.

Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.43.

Bio-techne Corp.’s earning per share (EPS) jumped 8.16% since last year same period to 0.53 in the Q2 2025. This indicates that the Bio-techne Corp. has generated 8.16% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q2 2025.